Histidine supplementation for treatment of anaemia of uraemia.Br Med J 1975; 2 doi: https://doi.org/10.1136/bmj.2.5970.530 (Published 07 June 1975) Cite this as: Br Med J 1975;2:530
- M J Blumenkrantz,
- D J Shapiro,
- M E Swendseid,
- J D Kopple
The effects of supplemental histidine on the anaemia of 16 chronically uraemic patients and 26 patients undergoing maintenance dialysis were assessed. Patients were given either L-histidine 4 g/day or placebo for a mean of 17-5 weeks in a randomized double-blind controlled study. Haemoglobin and packed cell volume increased slightly and to a similar degree in the patients on dialysis receiving placebo and histidine, but this change was statistically significant only in those on placebo. Plasma histidine rose significantly in the histidine-treated patients undergoing dialysis and decreased in the uraemic patients receiving placebo. These results suggest that supplementary L-histidine in patients with uraemia or patients undergoing maintenance dialysis does not improve anaemia.